News & Views | Published:

CHRONIC KIDNEY DISEASE

Kidney disease in the Global Burden of Disease Study 2017

Nature Reviews Nephrology (2019) | Download Citation

The analyses in the 2017 Global Burden of Disease Study demonstrate the growing burden of chronic kidney disease (CKD), mainly driven by population ageing; absolute levels for every CKD metric considered rose significantly, whereas age-standardized rates were fairly stable. The prevalence of key metabolic CKD risk factors, particularly obesity, also show a worrying increase.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

GBD data visualization hub: https://vizhub.healthdata.org/gbd-compare/

References

  1. 1.

    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018).

  2. 2.

    GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736–1788 (2018).

  3. 3.

    GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1859–1922 (2018).

  4. 4.

    GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1923–1994 (2018).

  5. 5.

    Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–2040 for 195 countries and territories. Lancet 392, 2052–2090 (2018).

  6. 6.

    Jager, K. J. & Fraser, S. D. S. The ascending rank of CKD in the Global Burden of Disease study. Nephrol. Dial. Transplant. 32 (Suppl. 2), 121–128 (2017).

  7. 7.

    Brück, K. et al. CKD prevalence varies across the European general population. J. Am. Soc. Nephrol. 27, 2135–2147 (2016).

  8. 8.

    Tonelli, M. et al. Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system. JAMA Netw. Open 1, e184852 (2018).

  9. 9.

    Pecoits-Filho, R. et al. Kidney disease in Latin America: current status, challenges and the role of ISN in the development of nephrology in the region. Kidney Int. 94, 1069–1072 (2018).

  10. 10.

    Bello, A. K. et al. Assessment of global kidney health care status. JAMA 317, 864–881 (2017).

Download references

Author information

Affiliations

  1. School of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK

    • Simon D. S. Fraser
    •  & Paul J. Roderick

Authors

  1. Search for Simon D. S. Fraser in:

  2. Search for Paul J. Roderick in:

Competing interests

The authors declare no competing interests.

Corresponding authors

Correspondence to Simon D. S. Fraser or Paul J. Roderick.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41581-019-0120-0

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing